Genobio ya sake yin jagora --Ka'idodin masana'antu na "Kit ɗin Gwajin Kwayoyin Endotoxin" an fitar da shi bisa hukuma

Wani sabon wurin farawa don ma'aunin masana'antu

Bayan YY/T 1729-2020 "Fungi (1-3) -β-D glucan determination kit", YY/T 1793-2021 "Bacterial Endotoxin Determination Kit" wanda Genobio ya tsara za a sake shi a cikin 2021 A ranar 9 ga Satumba, an amince da shi. ta Hukumar Kula da Magunguna ta Jiha kuma ta fito a hukumance.Za a fara aiwatar da ƙa'idar a kan Maris 1, 2023.

Shirye-shiryen "Kit ɗin Test Kit na Bacterial Endotoxin" an shirya shi ta National Medical Clinical Laboratory da In Vitro Diagnostic System Standardization Technical Committee (TC136), kuma an ƙaddamar da shi bisa hukuma a cikin Afrilu 2019. Tare da Genobio Pharmaceutical Co., Ltd. na farko daftarin aiki, hade tare da Beijing Medical na'urar Inspection Cibiyar, Beijing Medical na'urar Evaluation Center, Shanghai Clinical Testing Center, Beijing Jinshanchuan Technology Development Co., Ltd. (wasu na gaba ɗaya mallakar Reshen) da kuma da yawa sauran raka'a tare da aka tsara da kuma tsara.

A matsayin babban kamfani a cikin masana'antar naman gwari / ƙwayoyin cuta cikin sauri na dubawa, Genobio ya himmatu ga ci gaba da haɓaka matsayin samfur.Fiye da shekaru 20, manyan matsayi na masana'antu da daidaitattun kasuwa suna jagorantar mu a matsayin jagorarmu, ci gaba da ci gaba tare da lokuta, ƙoƙarin samun kamala, da ci gaba da neman kyakkyawan aiki.Fitar da wannan ma'auni na iya daidaita ingancin samfuran a cikin masana'antu yadda ya kamata tare da haɓaka martabar masana'antar gwajin ƙwayoyin cuta ta ƙwayoyin cuta a duk fagen binciken in vitro.

Kit ɗin Gano Endotoxin na Bacterial (Hanyar Chromogenic)

Genobio za ta ci gaba da aiwatar da daidaitattun ayyukan tallatawa da aiwatarwa, da ba da shawarar haɓaka ingancin samfuran masana'antu.A lokaci guda, za a shirya ma'aikatan fasaha don gudanar da daidaitattun tallace-tallace da kuma horar da horarwa ga masu amfani da asibiti da dakin gwaje-gwaje a manyan asibitoci, da kuma "aika ma'auni zuwa kofa".

A nan gaba, Genobio za ta ci gaba da yin amfani da fa'idodin fasaha na jagoran masana'antu, ɗaukar himma don shiga cikin ƙirƙira wasu ƙa'idodin samfuran da suka danganci, ba da gudummawar ƙarfin nasa ga daidaita tsarin masana'antar bincike na in vitro, da kuma raka amintaccen ci gaban masana'antar likitancin kasata!